The Proteolytic Activation of Angiogenic and Lymphangiogenic Growth Factors in Cancer – Its Potential Relevance for Therapeutics and Diagnostics

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|16|1821-1842

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.16, 2014-05, pp. : 1821-1842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth Factors as Therapeutics for Diabetic Neuropathy

By  

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 47-59

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Angiogenic Growth Factors in Psoriasis: A Review

By  

Current Drug Metabolism, Vol. 19, Iss. 11, 2018-09 ,pp. : 910-916

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 579-594

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Granulocyte Apoptosis by Hemopoietic Growth Factors, Cytokines and Drugs: Potential Relevance to Allergic Inflammation

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 4, 2003-12 ,pp. : 339-347

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor and Its Receptors as Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 135-156

Bentham Science Publishers

Access to resources Recommend Favorite